期刊
LANCET
卷 376, 期 9752, 页码 1604-1615出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/S0140-6736(10)61355-4
关键词
-
资金
- Bill & Melinda Gates Foundation
- ExxonMobil
- NIH/NCRR UCSF-CTSI [UL1 RR024131]
The marginal costs and benefits of converting malaria programmes from a control to an elimination goal are central to strategic decisions, but empirical evidence is scarce. We present a conceptual framework to assess the economics of elimination and analyse a central component of that framework potential short-term to medium-term financial savings. After a review that showed a dearth of existing evidence, the net present value of elimination in five sites was calculated and compared with effective control. The probability that elimination would be cost-saving over SO years ranged from 0% to 42%, with only one site achieving cost-savings in the base case. These findings show that financial savings should not be a primary rationale for elimination, but that elimination might still be a worthy investment if total benefits are sufficient to outweigh marginal costs. Robust research into these elimination benefits is urgently needed.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据